United States Biotechnology & Medical Research

eXoZymes Inc (EXOZ)

Track

Ticker: EXOZ Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for eXoZymes Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
340.00
Quantity 53,978 +47.8%
Value US$3,740,801
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
173.13
Quantity 82,649 +29.6%
Value US$1,209,795
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
387.25
Quantity 69,364 +42.2%
Value US$3,444,848
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.78
Quantity 1,767 +83.9%
Value US$19,048
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.72
Quantity 121 +6.1%
Value US$1,297
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
11.10
Quantity 1,984 +inf%
Value US$22,022
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-10 2026-04-09 S Sale
3.4
Korman Tyler Paz

Chief Scientific Officer

Officer
53,978 +47.8%
340.00
US$3,740,801 		53,978 +47.8% 340.00 US$3,740,801
2026-04-10 2026-04-08 S Sale
3.4
Korman Tyler Paz

Chief Scientific Officer

Officer
82,649 +29.6%
173.13
US$1,209,795 		82,649 +29.6% 173.13 US$1,209,795
2025-07-02 2025-07-02 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
69,364 +42.2%
387.25
US$3,444,848 		69,364 +42.2% 387.25 US$3,444,848
2025-01-21 2025-01-17 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,767 +83.9%
10.78
US$19,048 		1,767 +83.9% 10.78 US$19,048
2025-01-21 2025-01-16 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
121 +6.1%
10.72
US$1,297 		121 +6.1% 10.72 US$1,297
2024-11-19 2024-11-15 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,984 +inf%
11.10
US$22,022 		1,984 +inf% 11.10 US$22,022
Explore more

More insider trading research around eXoZymes Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America